Jeffrey H Knapp - Net Worth and Insider Trading
Jeffrey H Knapp Net Worth
The estimated net worth of Jeffrey H Knapp is at least $20 dollars as of 2024-11-29. Jeffrey H Knapp is the Chief Commercial Officer of Affymax Inc and owns about 25,169 shares of Affymax Inc (AFFY) stock worth over $20. Details can be seen in Jeffrey H Knapp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey H Knapp has not made any transactions after 2012-03-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey H Knapp
Jeffrey H Knapp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey H Knapp owns 3 companies in total, including Aimmune Therapeutics Inc (AIMT) , Adamas Pharmaceuticals Inc (ADMS) , and Affymax Inc (AFFY) .
Click here to see the complete history of Jeffrey H Knapp’s form 4 insider trades.
Insider Ownership Summary of Jeffrey H Knapp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AIMT | Aimmune Therapeutics Inc | 2018-03-04 | Chief Operating Officer |
ADMS | Adamas Pharmaceuticals Inc | 2015-02-25 | Chief Operating Officer |
AFFY | Affymax Inc | 2013-02-15 | Chief Commercial Officer |
Jeffrey H Knapp Latest Holdings Summary
Jeffrey H Knapp currently owns a total of 1 stock. Jeffrey H Knapp owns 25,169 shares of Affymax Inc (AFFY) as of March 27, 2012, with a value of $20.
Latest Holdings of Jeffrey H Knapp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AFFY | Affymax Inc | 2012-03-27 | 25,169 | 0.00 | 20 |
Holding Weightings of Jeffrey H Knapp
Jeffrey H Knapp Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey H Knapp has made a total of 0 transactions in Affymax Inc (AFFY) over the past 5 years. The most-recent trade in Affymax Inc is the sale of 0 shares on March 27, 2012, which brought Jeffrey H Knapp around $0.
Insider Trading History of Jeffrey H Knapp
- 1
Jeffrey H Knapp Trading Performance
Jeffrey H Knapp Ownership Network
Jeffrey H Knapp Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Jeffrey H Knapp is the Chief Operating Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Jeffrey H Knapp Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey H Knapp. You might contact Jeffrey H Knapp via mailing address: 4001 Miranda Ave. Palo Alto Ca 94304.